Core Viewpoint - Guizhou BaiLing has applied for a confidential patent for its traditional Chinese medicine formulation "Tang Ning Tong Luo," aimed at treating diabetes and its complications, marking a significant milestone in the field of traditional medicine in China [1][3]. Group 1: Company Developments - The confidential patent application for "Tang Ning Tong Luo" has been accepted by the National Intellectual Property Administration, indicating the technology's strategic importance to national interests [1]. - "Tang Ning Tong Luo" is the first traditional Chinese medicine formulation to receive such a patent, highlighting its unique value in treating Type 2 diabetes and its complications [3]. - The patent covers a wide range of treatment areas, including Type 2 diabetes, diabetic retinopathy, diabetic foot disease, erectile dysfunction related to diabetes, and diabetic kidney disease, providing comprehensive protection for the entire disease cycle [3]. Group 2: Industry Context - Diabetes has become a major public health challenge globally, with China having the highest number of patients, totaling 148 million [2]. - The global diabetes treatment market is substantial, yet it is predominantly dominated by imported products, with a significant lack of effective treatment options for complications [2]. - The acceptance of the confidential patent for "Tang Ning Tong Luo" coincides with the rapid expansion of China's diabetes drug market, potentially transforming the treatment landscape for diabetes both domestically and globally [4].